New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines
July 7, 2016
| By Diane Mapes / Fred Hutch News Service
Could persistent organic pollutants interfere with the effectiveness of vaccines? A new five-year collaboration between Fred Hutch and the Chinese Centers for Disease Control and Prevention is about to find out.
New analysis finds rare immune cells linked to HIV vaccine’s effectiveness
May 28, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
There are several kinds of immune responses that could protect against HIV infection. A new analysis has now found that a small but important subset of the immune cells known as T cells may be important for a working HIV vaccine.
VIDI disease modeler honored for her infectious-disease expertise
Dec. 21, 2009
| By Dean Forbes
Dr. Elizabeth "Betz" Halloran of the Fred Hutchinson Cancer Research Center's Public Health Sciences Division and Vaccine and Infectious Disease Institute has been elected a Fellow in the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.